IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
iRhythm Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$109.60+0.94 (+0.87%)
Close on Oct 19, 2026
- Market cap
- $3.61B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$72.20 (−39.71%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
iRhythm Holdings, Inc. grew revenue 25.6% to $825.34M over the twelve months to Jun 30, 2026. Free cash flow was $38.98M, up 39.8% from a year earlier.
Revenue
$825.34M
+25.6% vs. a year earlier
Operating income
-$24.87M
TTM Q2 2026
Free cash flow
$38.98M
+39.8% vs. a year earlier
EPS, diluted
-$0.43
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.61B
- P/E ratio
- –
- Price to sales
- 4.37
- Price to book
- 19.39
- Dividend yield
- –
- Free cash flow yield
- 1.08%
Fundamentals
- Revenue
- $825.34M
- Net income
- -$13.95M
- EPS, diluted
- -$0.43
- Free cash flow
- $38.98M
- Book value per share
- $5.65
- Diluted shares
- 33M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$825.34M+25.6% YoY
Gross profit
$589.74M+28.6% YoY
Operating income
-$24.87M
Net income
-$13.95M
EPS, diluted
-$0.43
Free cash flow
$38.98M+39.8% YoY
Reported periodTrailing twelve months